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Abstract
As a para-retrovirus, hepatitis B virus (HBV) is an enveloped virus with a double-stranded (DS) DNA genome that is replicated
by reverse transcription of an RNA intermediate, the pregenomic RNA or pgRNA. HBV assembly begins with the formation
of an ‘‘immature’’ nucleocapsid (NC) incorporating pgRNA, which is converted via reverse transcription within the maturing
NC to the DS DNA genome. Only the mature, DS DNA-containing NCs are enveloped and secreted as virions whereas
immature NCs containing RNA or single-stranded (SS) DNA are not enveloped. The current model for selective virion
morphogenesis postulates that accumulation of DS DNA within the NC induces a ‘‘maturation signal’’ that, in turn, triggers
its envelopment and secretion. However, we have found, by careful quantification of viral DNA and NCs in HBV virions
secreted in vitro and in vivo, that the vast majority of HBV virions (over 90%) contained no DNA at all, indicating that NCs
with no genome were enveloped and secreted as empty virions (i.e., enveloped NCs with no DNA). Furthermore, viral
mutants bearing mutations precluding any DNA synthesis secreted exclusively empty virions. Thus, viral DNA synthesis is
not required for HBV virion morphogenesis. On the other hand, NCs containing RNA or SS DNA were excluded from virion
formation. The secretion of DS DNA-containing as well as empty virions on one hand, and the lack of secretion of virions
containing single-stranded (SS) DNA or RNA on the other, prompted us to propose an alternative, ‘‘Single Strand Blocking’’
model to explain selective HBV morphogenesis whereby SS nucleic acid within the NC negatively regulates NC
envelopment, which is relieved upon second strand DNA synthesis.
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Introduction
The hepatitis B virus (HBV) is a global human pathogen that
chronically infects hundreds of millions and causes a million
fatalities yearly. It belongs to the Hepadnaviridae family, which also
includes several related animal viruses such as the duck hepatitis B
virus (DHBV) [1]. Hepadnaviruses contain a small (ca 3 kb),
partially double-stranded (DS) DNA genome enclosed within an
icosahedral capsid that is formed by 240 (or 180 in a minority
population) copies of the same viral protein, the core or capsid
protein (HBc), and is, in turn, coated with an outer envelope. As
pararetroviruses, hepadnaviruses assemble initially as immature
nucleocapsids (NCs), packaging an RNA pregenome (pgRNA).
These immature NCs undergo a process of maturation first to NCs
containing a single-stranded (SS) DNA (still considered immature)
and subsequently to mature NCs containing the DS DNA genome,
via reverse transcription of pgRNA inside the maturing NCs. Only
the mature NCs are then enveloped by the viral envelope or surface
(HBs) proteins and secreted extracellularly [2,3].
How genome maturation, within NCs, is coupled to envelop-
ment, from without, remains poorly understood. In particular, the
exact nature of the viral genome that is ultimately responsible for
regulating virion secretion is not yet clear. As SS RNA or DNA is
not secreted in virions but DS DNA, in either the major, relaxed
circular (RC) or minor, double-stranded linear (DSL) form, or
RNA-DNA hybrid, is [3–10], the prevailing model posits that the
accumulation of DS DNA as a result of second strand elongation
during reverse transcription triggers a structural change in the
maturing NC that, in turn, signals envelopment and secretion
[2,3,11,12]. Thus, this so-called maturation signal would emerge
on the mature NC only as reverse transcription approaches
completion and positively regulate virion secretion.
On the other hand, it has been suggested that HBV may secrete
virions containing no DNA at all. Two populations of HBV virion
particles were found to circulate in the blood of infected patients
decades ago, with one having a lighter buoyant density than the
other [13–15]. These so-called ‘‘light’’ virion particles contained
HBV envelope and core proteins but in contrast to the ‘‘heavy’’
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reflects DNA synthesis by the virion reverse transcriptase (RT)
using the endogenous DNA template. These light particles also
appeared empty under electron microscopy (EM) and were
assumed to be devoid of viral DNA. However, these early reports
did not directly determine the levels of viral DNA in the light
virions or whether they contained viral RNA or host nucleic acid.
A more recent study suggested that the light virion particles might
actually contain, instead of the normal capsid protein, an
aberrantly processed precore protein [16]. Another recent report
found that small amounts of enveloped HBV capsids devoid of
viral genome were secreted in transfected cell cultures but those
were deemed aberrant [9,16]. Thus, it has remained unclear if
HBV does secrete DNA-free virions and if so, whether it is part of
the normal virion morphogenesis process.
In our efforts to further define the nature of the viral genome
that underlies selective NC envelopment and virion secretion, we
have found that genome packaging or DNA synthesis, per se, was
actually not required at all for virion secretion as HBV mutants
able to form normal capsids but incapable of viral RNA packaging
or DNA synthesis, due to defects in RT, were secreted readily as
enveloped, empty (nucleic acid-free) virions. Furthermore, quan-
titative analyses of virion-associated DNA and capsids revealed
that the vast majority of virions secreted by the wild type (WT)
HBV in cell culture as well as in infected chimpanzees contained
no viral DNA. We propose a new model to explain the selective
HBV virion morphogenesis that can reconcile the seemingly
contradictory observations that virion formation selects stringently
for DS, and against SS, nucleic acid genome and yet empty HBV
virions devoid of any nucleic acid are secreted.
Results
Dramatic reduction of HBV DNA synthesis did not
decrease virion secretion
We obtained the first hint that HBV virion secretion may not
necessarily require viral DNA synthesis during our recent studies
on the anti-HBV effect of the cellular antiviral protein, Apobec3G
(A3G) [17]. As shown in Figure 1 and reported earlier [18], over-
expression of A3G led to a dramatic reduction of HBV DNA
associated with non-enveloped (naked) NCs as well as virions
secreted into the culture medium of transfected human hepatoma
(HepG-2) cells, which were resolved by native agarose gel
electrophoresis [19]. However, we found, unexpectedly, that the
amount of enveloped capsids secreted into the culture medium was
not decreased at all by A3G. The identity of the virion signal was
further verified by its association with, and dependence on, the
viral envelope proteins (Figures 1 & 2) and its authentic buoyant
density (see below). Naked capsids, which are routinely released
into cell culture medium via an unknown mechanism unrelated to
virion secretion and are of uncertain significance [20], were not
affected by A3G though their DNA content was reduced as
reported before [18]. HBsAg particles, which contain only the
viral envelope proteins but no capsids nor genome [1], were not
affected by A3G either (Figure 1). As HBsAg particles are
normally released in large excess (100-fold or more) over virions
[1], the surface protein signals detected in Figures 1 and 2 were
virtually all from the HBsAg but the virion and HBsAg comigrated
on the gel. This was also evidenced by the surface protein signal
migrating at the virion position from a mutant defective in core
and polymerase protein expression (C
-P
-) and thus could only
secrete HBsAg particles but no virions (neither empty nor DNA-
filled) at all (Figure 2B). These results indicated that viral DNA
synthesis might not be required for NC envelopment and virion
formation, in apparent contradiction to the prevailing maturation
signal hypothesis.
HBV mutants defective in RNA packaging or DNA
synthesis secreted enveloped capsids containing no viral
RNA or DNA
To further examine the relationship between genome content
and virion secretion in HBV, we determined the virion secretion
capacity of two mutants, Pol
- and Y63D; Pol
- is defective in
polymerase expression and unable to package viral RNA [21]
whereas Y63D is defective in DNA synthesis but fully functional in
RNA packaging [22] (Figure 2). Native agarose gel analyses of
HBV particles concentrated from the culture medium of
transiently transfected HepG-2 cells showed that as reported
before [5], pgRNA was not found in enveloped virions though
readily detectable in naked capsids of either WT or the Y63D
mutant (Figure 2). As anticipated, no viral RNA was detected in
either NC or virion particles from the Pol
- mutant, and only the
WT, but not the Y63D or Pol
- mutant, contained viral DNA in
virions or naked capsids. However, capsid protein signal was
clearly detected not only with the naked capsids but also with the
virion particles from the Y63D and Pol
- mutants, at levels at least
as high as those of the WT. As a negative control, the Env
- mutant
did not show any capsid or DNA signal migrating at the virion
position.
The co-migration of the putative Y63D and Pol
- virions with the
WT virions as well as with the envelope signals supported their
identification as authentic virions, which was further verified by
density gradient centrifugation (Figure 3; Figure S1). Native
agarose gel electrophoresis analyses of viral particles fractionated
on the CsCl gradient confirmed that enveloped capsids, i.e.,
virions, judged both by their density profile and mobility on the
agarose gel, were indeed secreted by the Y63D and Pol
- mutants
even though they contained no viral DNA. Consistent with the
notion that these enveloped capsids contained no nucleic acid
(viral or cellular; also see below) at all, the empty virions (marked
as peak #2) produced by the Y63D or Pol
- mutant had a slightly
lower density (as predicted by their lack of nucleic acid) than the
Author Summary
Hepatitis B virus (HBV), an important global human
pathogen and the main cause of liver cancer worldwide,
is classified as a para-retrovirus, as it replicates by reverse
transcription, i.e., copying of RNA to DNA, like retroviruses.
However, different from retroviruses that are RNA viruses
replicating via a DNA intermediate, HBV is a DNA virus that
replicates through an RNA intermediate. Like retroviruses,
HBV initially packages an RNA copy of its genome into
intracellular subviral particles. However, complete HBV
virions contain only a double-stranded (DS) DNA. The long-
standing model to explain this selective presence of DS
DNA in HBV virions postulates that DS DNA synthesis is
required to trigger virion secretion. We have found,
however, that virion secretion does not require any DNA
synthesis. Rather, the presence of the single-stranded RNA
(or the single-stranded DNA intermediate of reverse
transcription) negatively regulates virion formation. These
results thus change the prevailing paradigm in under-
standing HBV morphogenesis and also have important
implications for virus assembly in general. Furthermore,
they raise the important question regarding the role of
empty HBV virions identified here in viral replication and
pathogenesis.
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(peak #1). Furthermore, the capsid signal peak (marked as #2)
from the WT virion fractions also had a lower density than the
DNA peak. This later result suggested that most of the WT HBV
virions might also be empty such that the bulk virions (empty) had
a density lighter than the minor amounts of DNA-containing
virions.
Although small amounts of naked NCs migrated near the
position of the virions after the CsCl gradient fractionation step,
presumably in aggregated forms as a result of exposure to the high
salt concentration of the gradient as suggested earlier [9], the
naked NCs were clearly separated from the virions by the CsCl
density gradient fractionation such that there was no naked NC
contamination in the virion fractions (Figure 3). In addition,
consistent with numerous previous reports (see Introduction),
immature SS DNA was found in naked NCs but not in the virion
fractions (Figure S2; and also Figure 4 below), again indicating
clear separation of virions from naked NCs. On the other hand, no
naked capsid signal was detected near the virion position on the
agarose gel without the CsCl gradient centrifugation step as
indicated by the absence of any capsid protein or viral DNA signal
at the virion position from an HBV mutant defective in envelope
protein expression (Figure 2A, lanes 4, 12; Figure 2B, lane 5).
Furthermore, abolishing viral envelope protein expression elimi-
nated any capsid or viral DNA signal in the virion fractions on the
CsCl gradient (Figure S3), again indicating the secretion of the
empty virions, just like the DNA-containing virions, was absolutely
dependent on the viral envelope proteins and no naked capsids
contaminated the virion fractions following the density gradient
fractionation.
WT HBV secreted mostly empty virions in vitro and in vivo
To follow up on the above suggestion, we decided to quantify
the amount of HBV DNA and the capsid protein signals within the
virion fractions secreted by WT HBV transfected HepG-2 cells.
This revealed that most secreted HBV virions (from 92.5% in the
lighter fraction to 67% in the heavier fraction) from transfected
cells (Figure 4, lanes 15–18) were indeed devoid of any viral
DNA. These estimates were based on quantifications of the levels
of virion-associated capsids (based on 240 copies of core protein
per capsid) vs. the virion DNA. Although it is theoretically possible
that the DNA-free virion capsids may have reacted differently than
the DNA-containing virion capsids with the anti-HBc antibody
used for the western blotting, this was made unlikely by the fact
that the relative signals of the capsid proteins remained constant
across the lighter (virtually DNA-free) and heavier (with more
DNA-containing virions) fractions (Figure S4), whether the
capsid protein levels were estimated as native particles resolved
on an agarose gel or as denatured subunits resolved by sodium
dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE)
and detected by either a polyclonal antibody or a monoclonal
directed at a linear epitope at the N-terminus of the capsid protein
[23].
As reported earlier [13,14] using HBV positive human sera, two
kinds of WT HBV virions were observed by EM after negative
staining, with either a filled or empty looking inner capsid under
EM (Figure 5A). However, for most virions, the stain did not
penetrate the envelope thus making it difficult to discern if the
capsids within the virions were filled or empty. To visualize better
the capsids contained in the virions, the virion envelope was
removed by detergent lysis [12,14] and the released capsids were
Figure 1. Inhibition of HBV DNA synthesis by Apobec3G did not block virion secretion. Culture media from HepG-2 cells transfected with
pCMV-HBV plus pA3G-Flag (lanes 2, 4, 6; A3G or Apobec3G), or plus vector control (lanes 1, 3, 5; control) were collected and viral particles
concentrated from the medium were resolved by agarose gel electrophoresis and transferred to nitrocellulose membrane. Viral DNA (lanes 1–2), and
the core (lanes 3–4) and envelope (lanes 5–6) proteins were detected sequentially using a
32P-labeled HBV DNA probe, the anti-core antibody, and
the anti-S antibody respectively, all on the same piece of membrane. V, virions, containing either RC DNA or empty; C, naked capsids, containing DNA
(mostly SS), RNA, or empty. The diagrams on the side depict the structures of the virions and capsids. Wavy line, viral RNA; straight single line, SS DNA;
concentric partial circle, RC DNA; hexagon, capsid; large circle, virion envelope; small circle, HBsAg particles (S, containing no capsid nor genome)
comigrating with the virions.
doi:10.1371/journal.ppat.1002255.g001
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detergent treatment, we found that the majority of the released
capsids (ca 70%) had an empty appearance consistent with their
containing no nucleic acid while the remaining showed a filled
appearance presumably containing the DS DNA (Figure 5B). We
also released the capsids from the Pol
- mutant virions using the
same method and found that all released Pol
- capsids showed the
empty appearance, consistent with their lower density and
containing no nucleic acid (Figure 5C). As higher concentrations
of capsids were obtainable from intracellular sources, more
detailed analyses of the empty and filled capsids, including 3-D
image reconstruction, were carried out on those capsids and are
described below (Figures 6 & 7; Figures S8 & S9).
Intrigued by these results, we decided to quantify the levels of
viral DNA and capsid protein in the sera of HBV infected
chimpanzees [24]. As shown in Figure 4 (lanes 1–7) and Figure
S5, the vast majority (97.8–99.7%) of HBV virions found in the
sera from all four infected chimpanzees harvested at two different
times post-infection contained no viral DNA. HBV virions in one
of the chimpanzee sera were also fractionated by CsCl density
gradient centrifugation. As with the virions released by transfected
cells in culture, the core protein peak (Figure S5B, lane 2) in the
serum virions had a lighter density than the DNA peak (Figure
S5B, lane 4), indicating again the majority of the WT virions in
the serum were DNA-free and had a lighter density. The core
protein signal in the DNA peak fraction (lane 4) was below the
limit of detection since our core protein Western blotting had a
sensitivity of ca 1 ng/lane while the Southern blotting had a
sensitivity of less than 2.5 pg/lane (Figure 4). The virion DNA
secreted by the infected chimpanzees in vivo migrated mostly just
Figure 2. Analyses of HBV virion secretion by native agarose gel electrophoresis. WT or mutant HBV genomes (Pol
-, defective in pgRNA
packaging; Y63D, competent in pgRNA packaging but defective in DNA synthesis; Env
-, envelope deletion; C
-P
-, deficient for both core and
polymerase expression) were transfected into HepG-2 cells. Viral particles concentrated from the culture medium were resolved by agarose gel
electrophoresis and transferred to nitrocellulose membrane. Viral DNA (A, lanes 1–4) or core (A, lanes 9–12; B, lanes 1–5) and envelope proteins (A,
lanes 13–16; B, lanes 6–10) were detected as in Figure 1. Viral RNA (A, lanes 5–8) was detected as for viral DNA, except that the samples were
resolved on a separate gel that was not treated with NaOH prior to transfer and the membrane probed with a plus-strand specific riboprobe. V,
virions, containing either RC DNA or empty; C, naked capsids, containing DNA, RNA, or empty. The diagrams on the side depict the structures of the
virions and capsids as described in Figure 1.
doi:10.1371/journal.ppat.1002255.g002
Secretion of Genome-free Hepatitis B Virion
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1–7), typical for the incompletely DS HBV virion RC DNA
isolated from infected patients [10,25]. For reasons yet to be
understood, HBV virion DNA secreted by the transfected
hepatoma cells in vitro appeared more fully DS [26], migrating
above the 3 kb linear DNA (Figure 4, bottom, lanes 15–18).
As the HBsAg particles arepresent in largeexcess (100–1,000 fold
or more) over virions [1] and we detected also a large excess of
empty virions over DNA-containing ones (with total virion core
proteins reaching 1–3.75 mg/ml or1.6–4.4610
11 virions/ml), it was
of interest to estimate the levels of HBsAg in the sera from the
infected chimpanzees. To this end, purified recombinant HBsAg
(eEnzyme) was used a quantitative standard for western blotting.
Due to the undefined oligomeric states (a mixture of monomers,
dimers and higher order oligomers; eEnzyme) of the HBsAg
standard, it was resolved by SDS-PAGE along with different
dilutions of two serum samples from the same chimpanzee, one
before and one after HBV infection. The surface proteins were
detected using a rabbit polyclonal antibody that can recognize the
denatured HBsAg (Figure S6A) and the HBsAg concentration in
the HBV-positive serum was estimated based on comparison with
the standard. The HBsAg concentrations in the other chimpanzees
were then estimated by comparison to this serum after they were
resolved together on an agarose gel (Figure S6B). Our estimates of
the serum HBsAg levels in all four infected chimpanzees ranged
from 124–1,899 mg/ml, or ca 3610
13–4.4610
14/ml assuming 100
copies of the small surface protein per HBsAg sphere [1,27]. Thus,
the HBsAg levels were ca 167- to 1,688-fold above the virions (both
DNA-containing and empty). These estimates were in good
agreement with earlier estimates of HBsAg concentrations in the
serumofHBVinfectedhumanpatientsof10
13/mlor40 mg/ml[28]
to more recent quantifications of up to 10
15 or 4 mg/ml [29–31].
Empty HBV capsids were assembled in human cells that
did not package non-specific RNA
The secretion of HBV virions containing no nucleic acid at all
implied that empty HBV capsids, containing no viral or cellular
Figure 3. Analyses of HBV virion secretion by CsCl density gradient analyses. WT or mutant HBV genomes were transfected into HepG-2
cells and viral particles concentrated from the culture media as in Figure 1. The concentrated media were then fractionated by CsCl gradient
centrifugation. Gradient fractions were analyzed by resolving viral particles on native agarose gels. HBV DNA (panel 1), RNA (panel 3), and core
protein (panels 2, 4, 5) were detected as described in Figures 1 & 2. WT, panels 1 & 2; Y63D, panels 3 & 4; Pol
-, panel 5. The numbered fractions mark
the DNA-containing (#1) or DNA-free (#2) virion peaks, and the naked capsid peaks containing viral DNA or RNA (#3) or no nucleic acid (empty, #4),
with their respective buoyant densities indicated in bold at the bottom. Note that the first two panels from the top were derived from the same
membrane sequentially probed for viral DNA and the core protein, and the 3
rd and 4
th panels also from the same membrane sequentially probed for
viral RNA and core protein. The dashed lines are used to align the identical lanes from the same membrane. The diagrams on the side depict the
structures of the virions and capsids as described in Figure 1.
doi:10.1371/journal.ppat.1002255.g003
Figure 4. Quantitative analyses of DNA-filled and empty virions secreted by WT HBV in vitro and in vivo. HBV virions in the sera of
experimentally infected chimpanzees (lanes 1–7; 2 ml each serum) and purified from WT HBV transfected HepG-2 cells by CsCl density gradient
centrifugation (lanes 15–18; 30 ml each fraction), along with known amounts of HBV capsid standard (1–32 ng; lanes 8–13), were resolved by SDS-
PAGE; Virion-associated core protein was detected by western blot analysis using the anti-HBV core monoclonal antibody (top image). The virion DNA
released by SDS-protease digestion from the same chimpanzee sera (lanes 1–7; 2 ml each serum) and HepG-2 virion fractions (lanes 15–18; 2 ml each
fraction) were also resolved on an agarose gel, along with known amounts of HBV DNA (3 kb, 2.5–160 pg, lanes 8–14), and detected by Southern blot
analysis (bottom image). Lane 1 was from chimpanzee A0A006 at week 7 post-infection (PI); lanes 2 & 3, chimpanzee 1603 at week 15 and 16 PI,
respectively; lanes 4 & 5, chimpanzee 1618 at week 14 and 17; lanes 6 & 7, chimpanzee 1616 at week 20 and 23 PI. The amounts of HBV core protein
(top) and virion DNA (bottom) are indicated at the bottom of the lanes. The percentages of DNA-containing virions, calculated as the molar amounts
of HBV DNA divided by the molar amounts of HBV capsid (240 copies of core subunits per capsid) and multiplied by 100, are also indicated. Please
note that 15-fold more HepG-2 virions were loaded on the SDS-PAGE gel than on the agarose gel, which was taken into account in the calculation of
DNA-containing virions. F#, virion fraction number from the CsCl gradient. C, core protein; RC and DSL, RC and DSL DNA; X, blank lane (lane 14) on
the SDS-PAGE gel.
doi:10.1371/journal.ppat.1002255.g004
Secretion of Genome-free Hepatitis B Virion
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naked capsids harvested from the WT and Y63D transfections
peaked at a lower density (Figure 3 & Figure S1, peak #4;) than
the viral RNA or DNA signals (i.e., filled NCs) that peaked at a
higher density (peak #3). Although this capsid protein peak
contained some viral RNA or DNA, it likely represented the
overlap from the heavier, nucleic acid-containing NCs; earlier (still
lighter) capsid fractions contained little to no viral RNA or DNA.
The naked capsids of the polymerase-null mutant, being devoid of
any viral RNA or DNA (Figure 2) or cellular nucleic acid (see
Figure 6 below), peaked at the same light density as the capsid
protein peak (#4) from the WT and the Y63D mutant, lighter
than the RNA or DNA-containing NCs peak (#3).
To further verify that empty HBV capsids, containing no viral
or cellular nucleic acid, were indeed made in cells, we purified
intracellular capsids from transfected HepG-2 cells by sucrose
gradient centrifugation, resolved them on agarose gels along with
HBV capsids purified from E. Coli that are known to be filled with
nonspecific RNA [32–34], and detected the capsids (the protein
signal) or their associated nucleic acid with the highly sensitive
general protein (SYPRO Ruby) or nucleic acid (SYBR Gold) stain.
The detection sensitivity of the capsid-associated RNA (approx-
imately 8 ng capsids, or 1.6 ng RNA assuming each capsid
packages 3 kb RNA; Figure 6) was about 5-fold less than that of
purified RNA (approximately 0.3 ng RNA; Figure S7), presum-
ably due to the sequestration of RNA inside the capsids.
Therefore, instead of attempting to quantify the absolute amounts
of nucleic acid associated with the HepG-2 cell-derived capsids, we
used the E. Coli-derived capsids, not purified RNA or DNA, for
relative comparison.
The HBV Pol
- capsids did not show any detectable nucleic acid
signal (Figure 6, top, lane 10), as anticipated. Given that 244 ng
of Pol
- capsids (Figure 6, bottom, lane 10), estimated based on
comparison to the E. Coli-derived capsid standard (lanes 2–9), was
loaded and the RNA associated with 7.8 ng bacterially derived
capsids was detectable, the amount of RNA in the pol
- capsids, if
any, was thus less than 3% of that in the E. Coli-derived capsids.
The capsids harvested from WT HBV transfected HepG-2 cells
(Figure 6, lane 1) were found to contain detectable but much less
(ca 35%) nucleic acid when compared to the E. Coli-derived
capsids. Thus, the amount of WT HBV capsids purified from
HepG-2 cells loaded was 707 ng (Figure 6, bottom, lane 1) but its
nucleic acid content was equivalent only to 269 ng E. Coli-derived
capsid (Figure 6, top, lane 1). Titration of the WT HBV capsids
harvested from HepG-2 cells showed that the nucleic acid content
could be detected by the staining method when ca 100 ng of
capsid was loaded per lane (Figure S8). As the nucleic acid signal
detected in the WT HBV NCs was a mixture of capsid-associated
Figure 5. EM of HBV virions and virion-derived capsids. HBV WT or Pol
- virions released from transfected HepG-2 cells were fractionated by
CsCl density gradient centrifugation. The purified WT virions (A), or capsids released from the WT (B) or Pol
- (C) virions by NP40 treatment were
visualized by EM after negative staining. The arrows indicate the filled virion or virion-derived capsids and the arrowheads denote the empty virion or
virion-derived capsids. Note that the smaller particles in A represent the HBsAg spheres, which were much more numerous than the virions and were
removed by the detergent treatment in B and C.
doi:10.1371/journal.ppat.1002255.g005
Secretion of Genome-free Hepatitis B Virion
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-)
(lane 10) were purified from HepG-2 cells transiently transfected with pCMV-HBV and pCMV-HBV-Pol
-, respectively. WT HBV capsids purified from E.
Coli (lanes 2–9) were purchased from Virogen. The capsids were resolved by native agarose gel electrophoresis. Capsid-associated nucleic acid was
detected by SYBR Gold staining (top) and the capsid proteins were detected by destaining of the SYBR Gold signal and subsequent restaining of the
same gel with SYPRO Ruby (bottom). Note that A & B are from the same gel and the images in B are contrast-enhanced to display the weak signals.
C, capsids.
doi:10.1371/journal.ppat.1002255.g006
Figure 7. EM of intracellular capsids. Native HBV NCs purified by sucrose gradient centrifugation from transfected HepG-2 cells (WT, bottom left;
Pol
-, bottom right) were visualized by EM after negative staining with phosphotungstic acid. E. Coli-derived HBV WT (top left) or C-terminally
truncated (at position 144, C144 or DCTD; top right) capsids were examined in parallel as (RNA) filled and empty capsid controls, respectively. Two WT
capsids with distinct appearances, empty (arrowhead) and filled (arrow), are indicated.
doi:10.1371/journal.ppat.1002255.g007
Secretion of Genome-free Hepatitis B Virion
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(by ca 7 fold) detection sensitivity for DNA than RNA (Figure
S7), the amount of nucleic acid associated with the WT capsids
from HepG-2 cells, relative to that associated with the bacterially-
derived capsids that contain only RNA, were likely overestimated.
Thus, these results clearly indicated that the majority of WT HBV
capsids assembled in hepatoma cells were also empty.
The purified capsids were further subjected to negative staining
and EM (Figure 7), which showed that most (ca 80–90%) (Table
S1) HBV capsids harvested from the WT HBV transfected HepG-
2 cells, and virtually all capsids from the HBV Pol
- transfected
cells, displayed the thin-walled or empty appearance characteristic
of nucleic acid-free capsids such as the empty, C-terminally
truncated HBV capsids purified from E. Coli [15,35,36]. The rest
(ca 10–20%) of the WT HBV capsids from HepG-2 cells showed
the thick-walled or filled appearance consistent with their
containing RNA or DNA, similar to the full-length capsids
derived from E. Coli that are known to contain non-specific RNA.
To obtain further information about the interior contents of the
various HBV capsid populations, 3-D capsid maps were
reconstructed from selected negatively stained particles from the
EM images (Table S1). To check how the 3-D reconstruction
program translated the EM images into a 3-D model, the WT
HBV capsids from the HepG-2 cells were separated into two
groups, those that appeared to be empty and those that appeared
to be filled, and reconstructions were performed separately for
each group. The empty group resulted in a map with a hollow
core, and the filled group depicted electron densities inside of the
capsid (Figure S9). In comparison, the 3-D map of the HBV Pol
-
capsids also had a hollow core, in agreement with the results above
showing that these capsids contained no detectable nucleic acid
(Figures 2 & 6; Figure S8). Therefore, the results indicated that
a 3-D reconstruction from negatively stained EM images could
help distinguish between empty and filled viral particles. Capsids
assembled from the full-length and C-terminally truncated capsid
proteins expressed in E. Coli were also examined. The 3-D map of
the full-length capsids from bacteria showed electron densities
protruding inwards from the shell again consistent with the fact
they contained non-specific RNA. In contrast, the C-terminally
truncated capsids that appeared empty in the EM image also
showed a hollow core in the corresponding 3-D model. These
results agreed well with previously published cryo-EM structures
that revealed that the amount of the RNA content in the E. Coli-
derived HBV capsids depends on the length of the C-terminal
nucleic acid binding domain of the core proteins [37].
A previous report suggested that an aberrant precore protein,
lacking the C-terminal nucleic acid binding region of the core
protein but retains the precore region preceding the core protein
including the signal peptide, could assemble into abnormal capsids
that were enveloped and secreted [16]. The constructs we used
here to express the HBV core protein lacks the coding sequence
for part of the precore region including the precore initiation
codon and thus is not expected to produce any precore protein
[38]. Also, the core protein in the purified capsids or virions
migrated on SDS-PAGE as the full-length core protein standard
(Figure 4; Figures S4 & S5), suggesting that no truncation or
degradation occurred. To confirm directly that the HBV core
protein made in transfected cells indeed contained the C-terminal
region, we employed an antibody specific for the last 14 residues of
the core protein [39]. As anticipated, this antibody failed to detect
a C-terminally truncated core protein but could detect the core
protein in both the WT and Pol
- capsids; an antibody specific for
the N-terminal sequence of the core protein detected the full-
length as well as the truncated core proteins (Figure S10). These
results thus verified that the HBV core protein expressed in our
system was full-length and no aberrantly processed core or precore
proteins were made.
Discussion
Hepadnaviruses select only mature, DS DNA-containing, but
not immature, RNA- or SS DNA-containing NCs for envelopment
and extracellular secretion as virions. The molecular mechanism
underlying this selective virion morphogenesis, which is a defining
characteristic of all hepadnaviruses as pararetroviruses, remains to
be elucidated. We have provided here multiple, complementary
lines of evidence to demonstrate the secretion of empty HBV
virions with no viral or cellular nucleic acid, i.e., enveloped capsids
with no RNA or DNA. First, the secretion of empty virions, like
the DNA-containing ones, depended on the expression of the viral
envelope proteins as viral mutants defective in envelope expression
did not secrete any virions, empty or DNA-filled. Second, the co-
migration of the capsid and envelope proteins on the agarose gel
and their co-fractionation on the density gradient indicated the
capsids detected at the virion position were enveloped, as
confirmed by EM observation. Third, the buoyant density of the
empty virions were very close to the DNA-containing virions and
much lower than the naked NCs, as expected for enveloped
capsids, Fourth, the absence of viral DNA or RNA in the empty
virions was shown by the secretion of virions by the Pol
- mutant
that is incapable of packaging viral RNA or synthesizing DNA and
by the Y63D mutant that can package pgRNA but can’t synthesize
any DNA, and by the lack of detection of any viral RNA or DNA
by Southern blotting in these virions. Fifth, the absence of any
nucleic acid, viral or cellular, in the empty virions was indicated by
their slightly but reproducibly lower density than the DNA-
containing virions and the EM observation of virions containing
empty capsids as well as empty (mostly for the WT and entirely for
the Pol
- mutant) capsids released from the virions. Sixth, the naked
(non-enveloped) capsids from the WT were shown to be mostly,
and those from the Pol
- HBV entirely, empty, with no viral or
cellular nucleic acid. This was demonstrated by the absence of
viral RNA or DNA by Southern blot analyses, by EM observation
and 3-D image reconstruction, by their expected lighter density on
the CsCl gradient, and by direct measurement of total nucleic acid
in the capsids using sensitive nucleic acid staining methods. Thus,
in the case of the Pol
- virions, it would have been very difficult to
imagine that the secreted virions would have contained any RNA
or DNA since the intracellular Pol
- capsids, which were the
substrates for envelopment and virion formation, contained no
detectable nucleic acid. Also, given that (a) most of the WT
intracellular capsids contained no viral or cellular nucleic acid and
the remaining WT capsids contained either viral RNA or DNA,
(b) the intracellular capsids were the precursors to the enveloped
virions, and (c) viral RNA-containing capsids were excluded from
envelopment, it would have been difficult too to explain how the
DNA-negative WT virions would have contained any nucleic acid.
The secretion of enveloped capsids, without any nucleic acid
inside, is incompatible with the prevailing model of hepadnavirus
morphogenesis, whereby virion formation requires DS DNA
synthesis, i.e., NC maturation. Instead, we propose here that the
paradox, i.e., the seemingly stringent selection of DS DNA over
RNA or SS DNA in virion formation on one hand and yet
secretion of empty HBV virions devoid of any nucleic acid on the
other, can be resolved by invoking a new model, which we call
‘‘single strand (SS) blocking.’’ In this, negative signal model, the
presence of SS DNA or pgRNA in the immature NCs actively
prevents their envelopment by triggering a signal that negatively
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DNA for efficient virion secretion would NOT be due to a need to
accumulate a threshold amount of total nucleic acid with the
resulting increase in internal pressure, negative charge, genome
rigidity, or some other unknown effect, which in turn would trigger
a structural change (i.e., the maturation signal) on the maturing
NC leading to envelopment and virion secretion, as envisioned by
the classical maturation signal model (Figure 8B) [2,3,11,12].
Rather, the apparent requirement for DS DNA synthesis in virion
secretion reflects the need to remove the pgRNA or SS DNA, the
trigger of the blocking signal, so as to relieve its inhibition on NC
envelopment. Those capsids that do not package pgRNA (nor any
other RNA, see below) would not display this negative signal and
are thus competent for envelopment and secretion (as empty
virions) (Figure 8A). Although the secretion of empty virions
could be explained, in theory, by invoking a second envelopment
signal for the empty capsids, independent from that emerging on
the DS DNA-containing capsids, the simplest explanation is that
the empty capsids and the DS DNA-containing capsids share the
same envelopment signal.
The SS blocking model also predicts that decreasing the DS
DNA (thus the total amount of nucleic acid inside the NC) may
not block virion secretion. In support of this model, internally
deleted short (ca 2 kb or shorter) DNAs, derived from packaging
and reverse transcription of spliced HBV pgRNA have been
detected commonly in the blood of HBV-infected patients [40,41]
and in transfected cell culture medium [42–44]. In contrast, the
secretion of these shortened genomes in virions would be more
difficult to explain with the classical maturation signal model.
The secretion of empty HBV virions requires assembly of empty
capsids inside cells (Figure 8A). Three lines of evidence support
the existence of these empty capsids: (1) their lower buoyant
density than the nucleic acid-containing NCs, (2) lack of detection
of nucleic acid with highly sensitive, general nucleic acid stain, and
(3) their empty appearance under EM observation and 3-D capsid
image reconstruction. HBV capsids assembled in insect cells did
not package any cellular RNA either [45,46] and presumably
empty HBV capsids (so-called light cores) were also detected in the
liver of HBV infected patients [14,15,47]. Thus, in contrast to
capsids assembled in bacteria which package non-specific RNA
[32–34], HBV capsids assembled in insect and mammalian cells
do not package non-specific RNAs and are empty if they fail to
package the viral pgRNA. The underlying mechanism for this
difference remains to be elucidated but may be at least partly due
to capsid phosphorylation in mammalian and insect cells that
decreases its RNA binding activity [46,48,49].
We previously reported that the capsid protein associated with
the DHBV virions, as well as intracellular mature NCs containing
DS DNA, is unphosphorylated, in contrast to immature NCs that
consist of heterogeneously phosphorylated core protein [11]. If
DHBV, like HBV, secretes empty virions, it would suggest that not
all unphosphorylated DHBV capsids are mature and some
unphosphorylated DHBV capsids are in fact empty. If all
unphosphorylated DHBV capsids do contain DS DNA, it would
suggest that DHBV does not secrete empty virions, in contrast to
HBV. For the single strand blocking model to accommodate the
absence of empty DHBV virions, we suggest that DHBV capsids
may package viral pgRNA more efficiently or could package non-
specific RNA in host cells, unlike HBV. Consequently, empty
DHBV capsids may not be assembled in host cells and thus
unavailable for virion formation. Studies are currently underway
to determine the relationship between genome content and virion
secretion in DHBV.
How SS DNA or RNA triggers the proposed blocking signal is
not yet understood. One NC maturation model suggests that the
mature NC, by containing DS DNA and thus twice the amount of
negative charges as the immature NC containing either the SS
DNA or pgRNA, is destabilized as a result of the charge
imbalance, triggering an NC conformational change that may
be part of the maturation/envelopment signal [50,51]. In the
context of the single strand blocking model, it can be suggested
that NC destabilization due to the charge imbalance can not only
Figure 8. The single strand blocking hypothesis for selective hepadnavirus virion morphogenesis. The new model is presented in panel
A, in comparison with the classical maturation signal model depicted in panel B. See Discussion for details.
doi:10.1371/journal.ppat.1002255.g008
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also from the lack of any nucleic acid within the empty capsids.
Indeed, empty HBV capsids were shown to be unstable especially
under low salt conditions [51]. This structural instability may
preclude the generation of the blocking signal, thus allowing the
secretion of both empty and DS DNA-containing virions. The
secretion of SS DNA-containing virions by certain HBV core
mutants (the so-called immature secretion mutants) [9,52,53] and
an avian hepadnavirus (the snowgoose HBV or SGHBV) [54]
indicates that the blocking signal may be absent from, or
sequestered by, these immature NCs. In addition, low level
secretion of SS DNA-containing virions by the WT HBV has also
been observed [52,53] although we saw little, if any, SS DNA in
WT HBV virions in our experiments here. It is possible that the
stringency with which the single strand blocking signal controls
virion morphogenesis may vary, to some extent, with the viral
strains, the host cells, and the exact experimental conditions.
In conclusion, we propose that SS DNA or RNA within
immature hepadnavirus NCs triggers a blocking signal that
negatively regulates their envelopment and secretion, thus
ensuring the secretion of only DS DNA (or RNA-DNA hybrid)
in virions. However, empty capsids assembled in host cells that are
devoid of any viral or cellular nucleic acid, thus lacking the
negative signal, can be enveloped and secreted as ‘‘empty’’ virions
containing capsids but no nucleic acid. Therefore, the long-sought-
for maturation signal, a positive signal for envelopment, may in
fact represent the removal of this negative signal, as the maturing
NC retains ever-shorter SS DNA due to second (plus-) strand
DNA elongation. In common with the maturation signal
hypothesis, the SS blocking hypothesis also entails an as yet ill-
defined structural change accompanying plus-strand DNA elon-
gation (i.e., loss of the blocking signal). However, the blocking
hypothesis predicts that mature, DS DNA-containing NCs share a
structural characteristic with empty capsids (both lacking the
blocking signal) and furthermore, this characteristic is absent from
the pgRNA or SS DNA-containing NCs. The potential patho-
physiological significance, if any, of the empty HBV virions
remains to be determined. Among other possibilities, these empty
virions may function as immune modulators, defective interfering
particles, and markers of viral production or tissue damage
[13,55]. As the decision to secrete DNA-filled vs. empty virions is
actually made at an earlier step during HBV assembly, i.e., during
NC formation and pgRNA packaging (Figure 8A), the relative
abundance of these two different virion populations reflects the
efficiency of pgRNA packaging and may be a convenient marker
for monitoring this complex step in the HBV life cycle that
requires not only the viral RT and core proteins and pgRNA but
also cellular factors [56,57].
Methods
Plasmids
pCMV-HBV contains the HBV (ayw) 1.1-mer over-length
genomic sequence driven by the cytomegalovirus (CMV) imme-
diate-early promoter [38]. pCMV-HBV-Pol
- and pCMV-HBV-
Env
- were derived from pCMV-HBV and are defective in
polymerase and envelope protein expression, respectively [26].
pCMV-HBV-Core
-Pol
- was derived from pCMV-HBV-Pol
- by
introducing a 4 nt (GATC) insertion at position 1986 creating a
frameshift mutation after codon 30 in the core gene. pCMV-HBV-
Y63D bears a Y63D substitution in the RT gene eliminating DNA
synthesis [22]. All site-specific mutations were confirmed by
automated DNA sequencing. pA3G-Flag expresses the Flag-
tagged human Apobec3G protein [18].
Transient transfection and stably transfected cell line
The human hepatoma cell line HepG-2 were transfected by
FuGene 6 (Roche) [18,58]. The HepAD38 cell line was derived
from HepG-2 cell and replicates HBV in a tetracycline (Tet)-
repressible manner [59].
Analyses of viral core protein expression and DNA
synthesis
Core protein expression levels in the cytoplasmic lysate were
analyzed by SDS-PAGE and western blotting using the anti-HBV
core antibody (Dako, a rabbit polyclonal antibody; or a mouse
monoclonal specific for the N-terminal end of the core protein
[23]) as described previously [18,58]. Briefly, primary antibodies
were diluted at 1:1,000 and incubated with proteins bound to
Immobilon-P membrane (Millipore) overnight. Secondary anti-
mouse or anti-rabbit peroxidase labeled antibodies were used at
1:20,000 dilution. Chemilluminescence was used for detection of
the bound antibody. A rabbit polyclonal antibody specific for the
last 14 residues of the HBV core protein [39] was used where
indicated to specifically detect the C-terminal sequence of the core
protein. Virion- or naked capsid-associated DNA was isolated and
analyzed by Southern blotting as described previously [18,58].
Native agarose gel analysis of capsids and capsid-
associated nucleic acid
Native HBV NCs were purified from transfected HepG-2 cells
by sucrose gradient centrifugation [11,60]. Recombinant HBV
capsids purified from bacteria were obtained from Virogen.
Purified NCs and capsids were resolved by native agarose gel
electrophoresis [18,58,61,62] and the gel was stained by SYBR
Gold (Invitrogen) to detect RNA and DNA; after destaining with
10% methanol and 7% glacial acetic acid for 2 hr, the same gel
was restained with SYPRO Ruby (Sigma) to detect proteins. The
protein and nucleic acid signals were detected and quantified by
using a Molecular Imager (BioRad FX-PRO Plus).
Analysis of virion secretion and CsCl density gradient
centrifugation
Culture medium containing HBV virions and naked NCs was
concentrated by polyethylene glycol precipitation and digested
with DNase I (1 mg/ml at 37uC for 1 h) to eliminate residual
plasmid DNA and fractionated by isopycnic CsCl gradient
ultracentrifugation [7,11,61] to remove naked (non-enveloped)
NCs. Purified virion fractions or DNase digested concentrated
medium samples were analyzed by native agarose gel electropho-
resis as described [63]. Encapsidated RNA or DNA in viral
particles was detected using
32P-labeled RNA or DNA probe as
indicated, followed by detection of core proteins associated with
virions or naked NCs on the same membrane using the anti-core
antibody. Goat polyclonal anti-HBV surface protein (Dako) was
then used to detect the viral envelope proteins after stripping the
membrane. The nature of virion DNA was determined by
Southern blotting after extraction from purified virions using
SDS/proteinase K digestion [7,11]. The core protein associated
with virions was also analyzed by SDS-PAGE and western blot
analysis as described above. Sera from HBV infected chimpanzees
have been described before [24]. DNA levels were quantified using
phosphoimaging following Southern blot analysis and protein
levels using densitometry following western blot analysis. Viral
DNA and core protein standards were used to generate standard
curves from which sample virion DNA and core protein levels
were quantified. To estimate the levels of HBsAg, purified
recombinant HBsAg (eEnzyme) was used as a quantitative
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envelope proteins were detected by a polyclonal rabbit anti-HBs
antibody (Virostat). To prepare virion-derived capsids for EM, the
virion fractions were treated with 1% NP40-10 mM dithiothreitol
(DTT) for 30 minutes on ice to remove the viral envelope and
release the capsids [12,14]. The released virion capsids, along with
complete virions were observed under EM after neagative staining
as described below.
EM and 3-D image reconstruction
For each sample, an aliquot of 3 ml was placed on a freshly
glow-discharged continuous carbon coated copper grid. Phospho-
tungstic acid negative stain was applied by standard drop method
and the sample was examined in JEOL 1400 TEM at 120 kV. For
the 3-D reconstruction, 10–20 micrographs were collected with a
Gatan Orius SC1000 CCD camera with Digital Micrograph at a
calibrated magnification of 22,510X and 27,845X. Viral particles
were selected and processed using Robem [64]. The reconstruc-
tion processes were performed without CTF correction using
icosahedral averaging with the program Auto3dem, which
generated a random model directly from the raw data as the
initial starting structure [64]. The final resolution was determined
where the Fourier shell correlation fell below 0.5 as reported in the
summary output file of Auto3dem. The number of viral particles
selected, the final resolution and diameters of the 3-D reconstruc-
tions are listed in Table S1. The final pixel sizes were 1.26 for the
WT HBV capsids and 2.52 for all other constructs. The final
reconstructions were colored radially using the program Chimera
[65].
Supporting Information
Figure S1 Quantification of CsCl density profiles of
HBV virions and naked capsids. The relative levels of HBV
DNA, RNA, core protein, and surface proteins associated with the
virions or naked capsids in the culture medium of HepG-2 cells
transfected with the WT (top), Y63D (middle), or Pol- (bottom)
HBV constructs were plotted across the CsCl density. Note that
the surface proteins were only detected in virion fractions and the
viral RNA only in naked capsid fractions. The numerals denote
the peak densities of DNA-filled virions (1), empty virions (2), DNA
or RNA filled naked capsids (3), or empty capsids (4). The Y-axis
represents percent of the total virion or naked capsid signal in each
virion or capsid fraction. Virion and naked capsid fractions were
quantified separately due to the lower overall virion signals as
compared to naked capsids.
(TIF)
Figure S2 Southern blot analysis of HBV DNA associat-
ed with virions and naked capsids fractionated by CsCl
gradient centrifugation. pCMV-HBV was transfected into
HepG-2 cells and viral particles concentrated from the culture
medium were fractionated by CsCl gradient centrifugation.
Individual fractions were treated with SDS/proteinase K to
release the viral DNA, which was then resolved by agarose gel
electrophoresis and detected by Southern blotting using an HBV
DNA probe. RC, relaxed circular DNA; DSL, double-stranded
linear DNA; SS, single-stranded DNA.
(TIF)
Figure S3 Lack of virion secretion by the HBV mutant
defective in envelope protein expression by CsCl density
gradient analysis. The envelope-deficient mutant HBV
genome was transfected into HepG-2 cells and viral particles
concentrated from the culture media as in described Figure 1.
The concentrated media were then fractionated by CsCl gradient
centrifugation. Gradient fractions were analyzed by resolving viral
particles on native agarose gels. HBV DNA (top) and core protein
(bottom) were detected as described in Figure 1. The numbered
fractions mark the DNA-containing (#1) or DNA-free (#2) virion
peaks (both absent from this mutant), and the naked capsid peaks
containing viral DNA or RNA (#3) or no nucleic acid (empty,
#4), with their respective densities indicated in bold at the bottom.
The diagrams on the side depict the structures of the capsids as
described in Figure 1.
(TIF)
Figure S4 Similar reactivity of HBV capsids and core
subunits with two different anti-HBc antibodies. The
virion fractions isolated from the culture medium of WT HBV-
transfected HepG-2 cells by CsCl gradient fractionation were
resolved by native agarose gel electrophoresis (A) or SDS-PAGE
(B). The HBV core protein was detected using the mouse
monoclonal (top) or the rabbit polyclonal antibody (A, middle;
B, bottom). The viral DNA was detected by reprobing the same
membrane that was used for core protein detection by using an
HBV DNA probe (A, bottom). The direction of centrifugation is
indicated by the arrow. The virion core protein peak (containing
mostly empty virions) is shown in lane 2 and the virion DNA peak
is in lane 3. The fraction shown in lane 1 contained little DNA and
contained almost entirely empty virions.
(TIF)
Figure S5 Analysis of HBV virions in chimpanzee sera
before and after CsCl gradient fractionation. A. Two
HBV positive, (+), chimpanzee serum samples (chimpanzee 1616
at week 20 and 23 post-infection or PI; lanes 1–2) and four HBV
negative, (-), serum samples (from the same four chimpanzees
shown in Figure 4 but before HBV infection; lanes 3–6) were
resolved by agarose gel electrophoresis (top) or SDS-PAGE
(bottom) and the viral core protein was detected by western
blotting using the anti-HBV core antibody. B. HBV virions in the
week 7 PI serum from chimpanzee A0A006 were fractionated by
CsCl gradient ultracentrifugation and the individual fractions
(lanes 1–6), along with the crude serum input (lane 8) and the pre-
infection serum (lane 7) from the same chimpanzee were analyzed
by agarose gel electrophoresis and Southern blotting to detect viral
DNA (top) or by SDS-PAGE followed by western blotting to
detect the viral core protein (bottom). Intracellular (IC) HBV
capsids purified from HBV transfected HepG-2 cells were loaded
in lane 9 (bottom) as a control. V, virion; C, core protein. Note the
lack of cross-reactivity of the anti-core antibody to the pre-
infection serum samples by either the agarose gel or SDS-PAGE
analysis (A & B). The direction of centrifugation is indicated by the
arrow.
(TIF)
Figure S6 Estimatation of HBsAg levels in the sera of
HBV infected chimpanzees. A. The levels of HBsAg from the
indicated amounts of the week 14 post-infection (lanes 1–3) or pre-
infection (lanes 4–6) serum from chimpanzee 1618 were estimated
by comparison with a dilution series of HBsAg standard (lane 7–
11, containing the small surface protein or p24, the most abundant
of the three viral envelope proteins; eEnzyme). The samples were
resolved by SDS-PAGE and HBsAg was detected by western
blotting using the rabbit anti-HBs antibody (Virostat) able to
recognize denatured surface proteins on SDS-PAGE as well as
HBsAg particles resolved on agarose gels. SDS-PAGE was used
due to the uncertain nature of the oligomeric state of the HBsAg
standard. The amount of HBsAg (mainly the two small surface
proteins p24 and gp27) in the HBV positive serum was estimated
Secretion of Genome-free Hepatitis B Virion
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small surface protein; gp33 and gp36, singly- and doubly-
glycosylated middle surface protein [27]. The large surface
proteins (p39 and gp42) were not definitively identified due to
their low abundance. The protein molecular weight markers (M)
are indicated on the right. B. The amounts of HBsAg in the other
chimpanzee serum samples were estimated by comparison with
the serum sample shown in lane 4 whose HBsAg concentration
was predetermined in panel A (1.17 mg/ml or 1170 ng/ml). The
serum sample (1 ml per lane, loaded in the same order as in
Figure 4, lanes 1–7) were resolved by native agarose gel
electrophoresis and detected by western blotting. The titers of
HBsAg in the serum samples were calculated from the estimated
HBsAg concentrations assuming 100 copies of surface protein per
HBsAg particle. The concentrations of the virions in the same
serum samples were calculated using the estimated virion core
protein amounts shown in Figure 4 assuming 240 copies of core
protein per capsid (virion).
(TIF)
Figure S7 Detection of DNA and RNA on agarose gel by
SYBR Gold staining. The indicated amounts of yeast tRNA
and a 1 kb DNA m. w. marker (NEB) were resolved on an agarose
gel and detected by SYBR Gold staining. Note that the 3 kb DNA
represents 25%, and the other DNA species, 8%, of the total DNA
loaded. The detection limit was approximately 300 pg for tRNA
and 40 pg for the 3 kb DNA.
(TIF)
Figure S8 Nucleic acid and protein staining of purified
HBV capsids. WT HBV NCs (lanes 10, 11) and HBV capsids
devoid of the polymerase (Pol
-) (lane 1) were purified from HepG-2
cells transfected with pCMV-HBV and pCMV-HBV-Pol
-, respec-
tively. WT HBV capsids purified from E. Coli (lanes 2–9) were
purchased from Virogen. The capsids were resolved by native
agarose gel electrophoresis. Capsid-associated nucleic acid was
detected by SYBR Gold staining (top) and the capsid proteins were
detected by destaining of the SYBR Gold signal and subsequent
restaining of the same gel with SYPRO Ruby (bottom). C, capsids.
(TIF)
Figure S9 3-D image reconstruction of HBV capsids.
Viral capsid structures were reconstructed from negatively stained
particles of E. Coli-derived full-length and the C-terminally
truncated (DCTD) capsids, as well as WT and Pol
- HBV capsids
purified from transfected HepG-2 cells. The top row shows the
surface renderings of the reconstructions and the bottom shows
cross-sections. All models are depicted at 1 s. Color key depicts
color range according to radial distance in angstrom.
(TIF)
Figure S10 WT and Pol- HBV genomes expressed HBV
core protein with complete C-terminal sequence in
transfected cells. WT HBV NCs (lanes 3 & 7) and HBV
capsids devoid of the polymerase (Pol-) (lanes 4 & 8) were isolated
from HepG-2 cells transfected with pCMV-HBV and pCMV-
HBV-Pol-, respectively. Full-length (FL; lanes 1 & 5) and C-
terminally truncated (at residue 144, DCTD; lanes 2 & 6) HBV
capsids purified from E. Coli were from Virogen. The core
proteins were resolved by SDS-PAGE and after transfer to
membrane, detected by sequential probing first with a rabbit
polyclonal antibody against the last 14 residues of the core protein
(anti-CTD, lanes 1–4) and then with a mouse monoclonal
antibody against the N-terminal core sequence (anti-NTD, lanes
5–8). C, full-length core protein; DCTD, C-terminally truncated
core protein.
(TIF)
Table S1 Overview of the 3-D reconstruction results.
(DOC)
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